[1]Patent:US2011/118251,2011,A1.Locationinpatent:Page/Pagecolumn41
1307245-86-8
[1]Patent:US2011/118251,2011,A1.Locationinpatent:Page/Pagecolumn22
[1]Patent:US2011/118251,2011,A1.Locationinpatent:Page/Pagecolumn42-43
[1]Patent:US2011/118251,2011,A1
[2]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[1]Patent:US2011/118251,2011,A1
[2]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[3]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[4]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[5]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[6]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
[7]OrganicProcessResearchandDevelopment,2015,vol.19,p.1568-1575
Title: Preclinical findings predicting efficacy and side-effect profile of LY2940094, an antagonist of nociceptin receptors.
Journal: Pharmacology research & perspectives 20161201
Title: Proof-of-Concept Study to Assess the Nociceptin Receptor Antagonist LY2940094 as a New Treatment for Alcohol Dependence.
Journal: Alcoholism, clinical and experimental research 20160901
Title: A Selective Nociceptin Receptor Antagonist to Treat Depression: Evidence from Preclinical and Clinical Studies.
Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20160601
Title: Discovery of a novel series of orally active nociceptin/orphanin FQ (NOP) receptor antagonists based on a dihydrospiro(piperidine-4,7'-thieno[2,3-c]pyran) scaffold.
Journal: Journal of medicinal chemistry 20140424
Title: Rorick-Kehn LM, et al. A Novel, Orally Bioavailable Nociceptin Receptor Antagonist, LY2940094, Reduces Ethanol Self-Administration and Ethanol Seeking in Animal Models. Alcohol Clin Exp Res. 2016 May;40(5):945-54.
